Pain Therapeutics Lands Patents for Extended-release Oxycodone Capsules

The patents cover the company's REMOXY extended-release oxycodone capsules.

Pain Therapeutics Inc. a biopharmaceutical company, today announced the issuance of four patents by the U.S. Patent and Trademark Office covering REMOXY (oxycodone) Extended-Release Capsules CII. These patents are the result of joint inventive work by scientists from both Pain Therapeutics and Durect Corporation. The four issued patents are licensed exclusively to Pain Therapeutics in the United States and international markets with regards to four opioid drugs.

No votes yet
Syndicate content